Saturday, July 11, 2026

Drug profile · INN

tozorakimab

tozorakimab is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 11
News articles 0
Drug details — tozorakimab
Class
Route
Patents
0
Programs
11
Data quality
0.70